Healthcare + Pharmaceuticals

Rising healthcare costs and an increase in worldwide demand for medical services has the healthcare industry struggling to provide superior care while maintaining a cap on rising costs.
Healthcare + Pharmaceuticals
As the industry is also confronted with wavering public trust and increased regulation, new approaches to business practices and fresh communications strategies are critical. In Russia and the CIS in particular, the industry is undergoing a transformation, led by government efforts to modernize, develop high technologies, expand internal production, and bring better care to more citizens for a lower price. Healthcare companies need to engage with their stakeholders in a more meaningful and insightful way.


PBN Hill+Knowlton Strategies offers a unique, integrated and strategic mix of public affairs, media relations, digital communications, and public health education to reach the key healthcare opinion leaders that matter most. The firm has worked with regional and international pharmaceutical manufacturers, hospitals and medical providers, medical technology and equipment suppliers and other industry players. We have also worked for governments to design health education campaigns to improve health outcomes and promote healthy lifestyles.


PBN H+K’s healthcare and pharmaceuticals clients have included Abbott Laboratories, Akrikhin, AstraZeneca, Baxter, Genzyme, GlaxoSmithKline, the Human Stem Cell Institute, Merck Serono, Pfizer and Pharmacy Chain 36.6.
 

Related contacts :

Alexey Brevnov
Vice President, Government & Public Affairs and Head of Healthcare Practice

phone: +7 495 775 0077
email: alexey.brevnov@hkstrategies.com